Home
Conditions
Liver Fibrosis

Clinical trial condition

Liver Fibrosis

Explore clinical trials studying Liver Fibrosis. Study availability and eligibility vary by location and protocol.

126 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Liver Fibrosis trial results

Not Yet Recruiting

Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia

NCT07011199

Conditions: Bile Duct Diseases, Biliary Atresia, Biliary Tract Diseases, +14 more
Locations: Dr. Kariadi General Hospital Medical Center Semarang, Central Java, Indonesia

View Trial Details

Not Yet Recruiting

Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments

NCT06918886

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +18 more
Locations: Bezmialem Vakif University Istanbul, Fatih, Turkey (Türkiye)

View Trial Details

Not Yet Recruiting

Assessment of Methotreaxate-induced Liver Fibrosis by Transient Elastography and Serological Markers

NCT06872073

Conditions: Digestive System Diseases, Fibrosis, Liver Cirrhosis, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Precise Evaluation Criteria for Histological Regression of NASH Fibrosis

NCT06364462

Conditions: Digestive System Diseases, Fibrosis, Liver Cirrhosis, +5 more
Locations: Not specified

View Trial Details

Completed

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.

NCT07069725

Conditions: Digestive System Diseases, Fibrosis, Hepatic Cirrhosis, +5 more
Locations: Research Site Stockholm, Sweden

View Trial Details

Completed

Early Liver Disease Breath Detection

NCT05935488

Conditions: Digestive System Diseases, Fibrosis, Liver Cirrhosis, +5 more
Locations: North Norfolk Primary Care Norwich, Norfolk, United Kingdom

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

NCT06750276

Conditions: Digestive System Diseases, Fibrosis, Hepatic Cirrhosis, +5 more
Locations: Research Site Chandler, Arizona, United States

Research Site Rialto, California, United States

Research Site Atlanta, Georgia, United States

Research Site Morehead City, North Carolina, United States

View Trial Details

Completed

Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy

NCT00326482

Conditions: Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, +9 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Incidence of Liver Disease-Related Outcomes in People With HIV

NCT06940375

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +16 more
Locations: Shanghai Public Health Clinical Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity

NCT01082419

Conditions: Adenocarcinoma, Biliary Cholestasis, Carcinoma, +20 more
Locations: University Hospital Bordeaux Bordeaux, France

View Trial Details

Liver Fibrosis

Liver Fibrosis trial results

Related conditions